BRSF — Brain Scientific Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Brain Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.164 | 0.261 | 0.273 | 0.785 | 0.748 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0.006 | 0.001 | 0.017 | 0.001 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.178 | 0.289 | 0.44 | 1.13 | 1.31 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0.002 | 0 | 0.315 | 0.209 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.18 | 0.291 | 0.44 | 13.4 | 11.7 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.227 | 1.19 | 5.21 | 4.01 | 7.42 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.234 | 1.19 | 5.24 | 14.1 | 7.43 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.054 | -0.896 | -4.8 | -0.695 | 4.32 |
Total Liabilities & Shareholders' Equity | 0.18 | 0.291 | 0.44 | 13.4 | 11.7 |
Total Common Shares Outstanding |